Rallybio to Present at the TD Cowen 44th Annual Health Care Conference
February 26 2024 - 8:00AM
Business Wire
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage
biotechnology company committed to identifying and accelerating the
development of life-transforming therapies for patients with severe
and rare diseases, today announced that Steve Uden, M.D., Chief
Executive Officer of Rallybio, will participate in a panel
discussion, “Orphan Bone & Neuromuscular Diseases,” at the TD
Cowen 44th Annual Health Care Conference on Monday, March 4, 2024
at 9:10 a.m. EST in Boston, MA.
A live webcast of the panel discussion will be accessible
through the Events and Presentations section of Rallybio’s website
at www.rallybio.com. A replay of the webcast will be available for
30 days following each presentation.
About Rallybio
Rallybio (Nasdaq: RLYB) is a clinical-stage biotechnology
company with a mission to develop and commercialize
life-transforming therapies for patients with severe and rare
diseases. Rallybio has built a broad pipeline of promising product
candidates aimed at addressing diseases with unmet medical need in
areas of maternal fetal health, complement dysregulation,
hematology, and metabolic disorders. The Company has two clinical
stage programs: RLYB212, an anti-HPA-1a antibody for the prevention
of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and
RLYB116, an inhibitor of complement component 5 (C5), with the
potential to treat several diseases of complement dysregulation, as
well as additional programs in preclinical development. Rallybio is
headquartered in New Haven, Connecticut. For more information,
please visit www.rallybio.com and follow us on LinkedIn and
Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240221212601/en/
Investor Contacts Ami Bavishi Head of Investor Relations
and Communications 475-47-RALLY (Ext. 282) abavishi@rallybio.com
Hannah Deresiewicz Stern Investor Relations, Inc. 212-362-1200
hannah.deresiewicz@sternir.com Media Contact Victoria
Reynolds Mission North 760-579-2134 rallybio@missionnorth.com
Rallybio (NASDAQ:RLYB)
Historical Stock Chart
From Apr 2024 to May 2024
Rallybio (NASDAQ:RLYB)
Historical Stock Chart
From May 2023 to May 2024